Evidence map›Paper›PMID 39404989›Full record

ArticleAnnals of surgical oncology2025

Failure to Rescue After Resection of Perhilar Cholangiocarcinoma in an International Multicenter Cohort.

Pim B Olthof, Stefan A W Bouwense, Jan Bednarsch, Maxime Dewulf, Geert Kazemier, Shishir Maithel, William R Jarnagin, Luca Aldrighetti, Keith J Roberts, Roberto I Troisi and 20 more

Abstract readMulticenter Study
In one paragraph

Article in Annals of surgical oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

30 authors.

Pim B Olthof *Department of Surgery, Erasmus Medical Center, Rotterdam, The Netherlands. p.olthof@erasmusmc.nl.
Stefan A W Bouwense *Department of Surgery, Maastricht University Medical Center+, Maastricht, The Netherlands.
Jan BednarschDepartment of Surgery, Maastricht University Medical Center+, Maastricht, The Netherlands.
Maxime DewulfDepartment of Surgery, Maastricht University Medical Center+, Maastricht, The Netherlands.
Geert KazemierDepartment of Surgery, Amsterdam UMC, Amsterdam, The Netherlands.
Shishir MaithelDivision of Surgical Oncology, Winship Cancer Institute, Emory University, Atlanta, GA, USA.
William R JarnaginHepatopancreatobiliary Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Luca AldrighettiHepatobiliary Surgery Division, IRCCS San Raffaele Scientific Institute and Vita-Salute San Raffaele Univeristy, Milan, Italy.
Keith J RobertsDepartment of Surgery, University Hospital Birmingham, Birmingham, UK.
Roberto I TroisiDivision of HPB, Minimally Invasive and Robotic Surgery, Transplantation Service, Federico II University Hospital Naples, Naples, Italy.
Massimo M MalagoDepartment of HPB- and Liver Transplantation Surgery, Royal Free Hospitals, University College London, London, UK.
Hauke LangDepartment of General, Visceral and Transplantation Surgery, University Medical Center, Mainz, Germany.
Ruslan AlikhanovDepartment of Liver and Pancreatic Surgery, Department of Transplantation, Moscow Clinical Scientific Centre, Moscow, Russia.
Andrea RuzzenenteDepartment of Surgery, Division of General Surgery, Unit of Hepato-Pancreato-Biliary Surgery, University of Verona Medical School, Verona, Italy.
Hassan MalikLiver Surgery Unit, Aintree University Hospital, Liverpool, UK.
Ramón CharcoDepartment of HBP Surgery and Transplantation, Hospital Universitario Vall d'Hebron, Universidad Autónoma de Barcelona, Barcelona, Spain.
Ernesto SparrelidDivision of Surgery and Oncology, Department for Clinical Science, Intervention and Technology, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
Johann PratschkeDepartment of Surgery, Campus Charité Mitte and Campus Virchow-Klinikum, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Matteo CesconGeneral Surgery and Transplant Unit, IRCCS- Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
Silvio NadalinDepartment of General and Transplant Surgery, University Hospital Tübingen, Tübingen, Germany.
Jeroen HagendoornDepartment of Surgical Oncology, University Medical Centre/Utrecht University, Utrecht, The Netherlands.
Erik SchaddeDepartment of Surgery, Rush University Medical Center Chicago, Chicago, IL, USA.
Frederik J H HoogwaterDepartment of Surgery, University Medical Center Groningen, Groningen, The Netherlands.
Andreas A SchnitzbauerUniversitätsklinikum Frankfurt, Klinik für Allgemein-, Viszeral- und Transplantationschirurgie, Frankfurt, Germany.
Baki TopalDepartment of Surgery, Catholic University of Leuven, Leuven, Belgium.
Peter LodgeDivision of Surgery, Department of Hepatobiliary and Liver Transplant Surgery, St James's University Hospital, Leeds, UK.
Steven W M Olde DaminkDepartment of Surgery, Maastricht University Medical Center+, Maastricht, The Netherlands.
Ulf P Neumann *Department of Surgery, Maastricht University Medical Center+, Maastricht, The Netherlands.
Bas Groot Koerkamp *Department of Surgery, Erasmus Medical Center, Rotterdam, The Netherlands.
Perihilar Cholangiocarcinoma Collaboration Group

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4M
NCI NIH HHS P30 CA008748
6 · The paper itself

Abstract

backgroundFailure to rescue (FTR) is defined as the inability to prevent death after the development of a complication. FTR is a parameter in evaluating multidisciplinary postoperative complication management. The aim of this study was to evaluate FTR rates after major liver resection for perihilar cholangiocarcinoma (pCCA) and analyze factors associated with FTR. PATIENTS AND

methodPatients who underwent major liver resection for pCCA at 27 centers were included. FTR was defined as the presence of a Dindo grade III or higher complication followed by death within 90 days after surgery. Liver failure ISGLS grade B/C were scored. Multivariable logistic analysis was performed to identify predictors of FTR and reported using odds ratio and 95% confidence intervals.

resultsIn the 2186 included patients, major morbidity rate was 49%, 90-day mortality rate 13%, and FTR occurred in 24% of patients with a grade III or higher complication. Across centers, major complication rate varied from 19 to 87%, 90-day mortality rate from 5 to 33%, and FTR ranged from 11 to 50% across hospitals. Age [1.04 (1.02-1.05) years], ASA 3 or 4 [1.40 (1.01-1.95)], jaundice at presentation [1.79 (1.16-2.76)], right-sided resection [1.45 (1.06-1.98)], and annual hospital volume < 6 [1.44 (1.07-1.94)] were positively associated with FTR. When liver failure is included, the odds ratio for FTR is 9.58 (6.76-13.68).

conclusionFTR occurred in 24% of patients after resection for pCCA. Liver failure was associated with a nine-fold increase of FTR and hospital volume below six was also associated with an increased risk of FTR.

Indexed as

Bile Duct NeoplasmsCholangiocarcinomaFailure to Rescue, Health CareHepatectomyKlatskin TumorPostoperative ComplicationsAgedFemaleFollow-Up StudiesHumansMaleMiddle AgedPrognosisRetrospective StudiesSurvival Rate

Identifiers

PMID39404989
PMCPMC11811460

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.